Table 1.
Demographic and Clinical Characteristics of Study Sample
SCZ (n=72) | PMD (n=25) | CON (n=72) | χ2/F Statistic | |
---|---|---|---|---|
Age (mean±SD) | 39.1±12.1 | 41.4±9.7 | 39.9±13.3 | 0.35 |
Age of Onset-Psychosis (mean±SD) | 23.8±9.6 | 24.7±7.4 | na | 0.19 |
Gender (% male) | 40.3% | 52.0% | 45.8% | 1.51 |
SES (mean±SD) | 3.5±1.00 | 3.2±1.0 | 3.2±1.0 | 2.37 |
Race (% African-American) | 56.0% | 56.9% | 41.7% | 3.74 |
Substance Use Disorder (Abuse or Dependence) | ||||
Alcohol | 18.1% | 44.0% | na | 6.71** |
Cannabis | 19.4% | 36.0% | na | 2.81 |
Cocaine | 9.7% | 24.0% | na | 3.26+ |
Stimulants | 2.8% | 12.0% | na | 3.23+ |
Hallucinogen | 4.2% | 8.0% | na | 0.56 |
Sedatives | 2.8% | 4.0% | na | 0.09 |
Opioids | 1.4% | 0.0% | na | 0.35 |
p<.07,
p<.01,
p<.001.